Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 3.98M | $4.0M | 9.34% | -123.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 416.9K | -- | 0.98% | +34.4K | 2026-06-30 |
| Geode Capital Management, LLC | 141.3K | -- | 0.33% | -16.2K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 64.9K | -- | 0.15% | -- | 2026-06-30 |
| BlackRock, Inc. | 52.0K | -- | 0.12% | +12.1K | 2026-06-30 |
| State Street Corp | 43.3K | -- | 0.10% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 39.1K | -- | 0.09% | -23.7K | 2026-06-30 |
| Northern Trust Corp | 34.9K | -- | 0.08% | +15.2K | 2026-06-30 |
| US Bancorp \de\ | 20.0K | -- | 0.05% | +3.1K | 2026-06-30 |
| Tower Research Capital LLC (TRC) | 3.3K | -- | 0.01% | -1.6K | 2026-06-30 |
